Skip to content

Corbus Pharmaceuticals Holdings, Inc.

CRBP

CIK 0001595097

← back to feed
Revenue (TTM)
$233.88K
−100.0% YoY Q1 May 2026
Net Income (TTM)
−$80.95M
−95.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$5.96
−60.3% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-37,475.5%
Q1 May 2026
Net Margin
-34,612.0%
Q1 May 2026
Free Cash Flow (TTM)
−$65.09M
Q1 May 2026
Cash
$25.66M
Q1 May 2026
Total Debt
$12.76M
Q1 May 2026
Shares Outstanding
18.53M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings